Part of a wave of litigation engulfing tech firms over using material to train AI models | 1yr
IP
Settlement ends all ongoing patent-related legal proceedings between the parties | 1yr
Incoming group will be based in New York, Washington DC and the Bay Area | 1yr
Dismissal marks latest round in long-running global dispute between pharma companies Merck KGaA and Merck Sharp & Dohme (MSD) | 1yr
Pan Lee and Don Wang join partners Jeannine Yoo Sano and Eric Krause in San Francisco | 1yr
Lawsuit filed in US alleges that fast fashion giant sells “knock off products to consumers on a global scale” | 1yr
The court awarded significant damages to a foreign fruit producer | 1yr
China was the leading country filer for patents and designs, while US took the top spot for trademarks | 1yr
Luxury brands can attract negative publicity for aggressively defending their trademarks, so striking the right balance is essential, write Freeths IP experts Iona Silverman, Dan Cahill and Kishan Pattni | 1yr
Clifford Chance acted for defendants in High Court case over reverse-engineering of mainframe technology | 1yr
Recruits will strengthen its Silicon Valley offering in emerging technologies like AI and medtech | 1yr
Freshfields leads Moderna to win in German court but pharma company is not so successful in the US | 1yr
Sneaker giant’s other claims against the online marketplace are rejected including false advertising | 1yr
Lenovo prevails over Ericsson in its bid to secure interim licence to use its 4G and 5G patents | 1yr
Platform firm continues to attract talent from top firms as it continues hiring push | 1yr
Lawyers, publishers and top musicians all had their say on closing day of consultation on use of copyrightable material to train AI models | 1yr
Sarah Gagan will team up with New York-based Amir Ghavi who joined from Fried Frank earlier this month | 1yr
Launch of latest Gen AI suit follows victory for Thomson Reuters in tussle with legal research outfit ROSS | 1yr
Herbert Smith Freehills’ Priyanka Madan reports on a case involving a Merck SPC which was keenly anticipated by both innovators and generic manufacturers | 1yr
Counsel will only be barred if they have ‘extensive administrative and financial powers’ within a company, court rules | 1yr